Background. In September 2008, an outbreak of pneumonia associated with an emerging human adenovirus (human adenovirus serotype 14 ) occurred on a rural Southeast Alaska island. Nine patients required hospitalization, and 1 patient died.
disease, pneumonia, conjunctivitis, cystitis, and gastroenteritis. The severity of illness also varies, ranging from asymptomatic infection to severe lower respiratory tract infection, viral sepsis, and death [1] . Although HAdVs are widely distributed and common, they rarely produce severe disease or death in a healthy immunocompetent individual or community outbreaks of severe disease. Seven species and 150 serotypes of HAdVs have so far been identified, and the clinical manifestations, patterns of infection, and disease severity vary by species, subspecies, serotype, and genetic subtype [2, 3] . For example, HAdVs of species C (serotypes 1, 2, 5, and 6) commonly cause upper respiratory tract infections in children, whereas those of species B (serotypes 3, 7, and 21) and E (serotype 4) are best known to cause outbreaks of febrile respiratory tract disease and pneumonia worldwide among older children, adults, and military recruits [1] .
HAdV serotype 14 (HAdV-14), a B2 HAdV subspecies, was first identified among military recruits in the Netherlands in 1955 and caused military and civilian outbreaks of pharyngoconjunctival fever and mild respiratory tract disease through the 1960s in Europe and Asia. This prototype HAdV-14 strain (referred to as the deWit strain) was rare by the 1990s, was not associated with hospitalization or death, and had not been identified in the Western Hemisphere [4] [5] [6] [7] [8] . In the United States, HAdV-14 emerged as a significant pathogen in 2006 when it was identified as the cause of several clusters of severe lower respiratory tract disease, including pneumonia, in both civilian and military settings [9] . A community outbreak in Oregon was associated with 29 hospitalizations and 7 deaths from 1 November 2006 through 1 July 2007 [10] . A US military training facility experienced sustained, high rates of HAdV-14 transmission over 5 months in 2007 among young, healthy recruits, which resulted in 23 hospitalizations and 1 death [11] . Notably, all HAdV-14 isolates recovered in the United States to date have been identical to each other but have differed from the prototype deWit strain in a number of respects, including the presence of a deletion of 6 base pairs (2 amino acids) in the fiber knob gene [12] .
On 22 September 2008, the Alaska Department of Health and Social Services (ADHSS) was notified of 10 cases of pneumonia, including 3 that resulted in hospitalization and 1 that resulted in death, among residents of a rural island in the southeastern part of the state. Laboratory testing at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, subsequently identified HAdV-14 in 6 of 13 respiratory tract swab specimens obtained from these patients with pneumonia. Because little is known about HAdV-14 infection in community settings, the ADHSS and the CDC initiated a collaborative investigation of this pneumonia outbreak on 12 October. We sought to learn more about the risk factors for severe disease and the patterns of transmission for this emergent HAdV variant.
METHODS
Outbreak setting. The outbreak occurred on an island located in Southeast Alaska that is accessible only by boat or plane. The island is roughly the size of the state of Delaware and has 4570 residents in 11 widely spaced communities that range in population from 35 to 1397 persons [13] . The island is rural, with a population density of !0.5 persons per square mile, which is half the density of the rest of the state of Alaska and 1/160 that of the United States as a whole. One-third of the island population is American Indian and Alaska Native (AIAN), although communities vary widely in racial makeup, which ranges from 3%-90% AIAN. Two medical clinics (clinics A and B) offer full-time primary care physician staffing. Both clinics have laboratory testing and X-ray radiographic capabilities, and one offers 24-h emergency care and 48-h low-acuity observation. Residents who require a higher level of inpatient or specialty care must be medically evacuated off the island. Two additional clinics serve the more remote island communities and lack full-time physician attendance.
Epidemiological investigation. Patients with a clinical diagnosis of acute respiratory tract infection or lower respiratory tract illness were identified at clinics A and B through review of clinic records and query of clinic staff. A case patient was defined as an island resident with an acute illness and clinical or radiological evidence of pneumonia who was 11 year of age and presented for care between 1 September and 27 October 2008. The illness was defined as severe if it resulted in hospital admission or death. For the case-control investigation, control participants were recruited from the community both by random door-to-door canvassing in the neighborhoods of the case patients and by random-digit dialing of published phone numbers. Control participants were matched 1:1 to case patients by age group (1-4, 5-19, 20-34, 35-49, 50-64, and у65 years), sex, and community of residence. Control participants who self-reported signs of febrile acute upper respiratory tract infection or acute lower respiratory tract illness in the 2 weeks preceding the onset of symptoms in the case patients to whom they were matched were excluded. All individuals who slept at least 5 nights per week in the household of any case patient or control participant were considered to be household members and were eligible to participate in the household contact component of the investigation. Because this was an emergency public health response to an outbreak, no review by the human ethics committee of the CDC was required.
Data on demographic characteristics, recent illnesses, symptoms, medical history, ill contacts, travel, and other possible exposures and risk factors were collected with a standardized survey that was administered by investigators to all participants. Data on household member demographic characteristics and symptom histories and the physical characteristics of each household were also collected with a survey administered by investigators to the head of each household. We attempted to collect a nasopharyngeal or oropharyngeal swab specimen and a serum sample from each case patient, control participant, and household contact at the time of interview. No convalescent serum samples were obtained. Clinical data from the medical records of case patients were abstracted, and radiographs and radiology reports were reviewed when they were available. Year 2000 demographic characteristics of the island communities were generated for comparison [13] . Household transmission of HAdV-14 was defined as having occurred if there was laboratory-confirmed evidence of HAdV-14 infection in any household contact of an HAdV-14-infected case patient or HAdV-14-infected control participant. To calculate the secondary attack rate of HAdV-14 among household members, we used as the denominator only those household members who had submitted specimens for laboratory testing. When more than 1 case patient resided in the same household, the patient with the earliest symptom onset date was designated as the primary case patient. For the purpose of the secondary attack rate calculation, the secondary case patient was considered to be a household contact.
Laboratory analysis. Respiratory tract swab specimens were cultured for a broad range of viral pathogens by use of MRC5, HEP2, and rhesus monkey kidney cell lines at the Alaska State Virology Laboratory (Fairbanks, AK). All respiratory tract specimens were also tested at the CDC in Atlanta, Georgia, by means of an HAdV-14-specific real-time polymerase chain reaction (PCR) assay as described elsewhere [10] . Levels of HAdV-14-neutralizing antibodies were measured using a modified version of a standard microneutralization assay [11, 14] . Serological evidence of HAdV-14 infection was defined as a titer of 11: 80. Persons whose specimens tested positive for HAdV-14 by either serological analysis or PCR were considered to be infected with HAdV-14. Case patients with no or poorly timed specimens but with close and sustained contact with an HAdV-14-infected person were designated as probable HAdV-14-infected case patients.
The timing of specimen collection among case patients was analyzed to assess possible misclassification of HAdV-14 status. The optimal time of collection of a respiratory tract swab specimen was defined as !14 days after symptom onset. A serum sample was considered to be optimally timed if it was collected у14 days after symptom onset.
Statistical analysis.
For the matched case-control investigation, matched odds ratios and 95% confidence intervals for the outcomes of pneumonia and HAdV-14 infection were first examined by means of univariate conditional logistic regression modeling. Variables identified as significant in the univariate analysis were entered into a multivariate conditional logistic regression model, and a backward selection algorithm was applied. The least significant variable was removed from the model iteratively until all remaining variables were statistically significant. However, if the removal of a nonsignificant variable resulted in a change in the odds ratio of a significant variable by at least 10%, it was retained in the final model to adjust for confounding. For all analyses, a P value of !.05 was considered to be statistically significant. Exact conditional logistic regression was used when categorical independent variables for casecontrol pairs contained !5 responses in a category. SAS (version 9.2; SAS Institute) was used for the analysis.
RESULTS
Outbreak and case-patient description. Thirty-nine patients met the definition of a pneumonia case patient. All presented for care between 3 September and 21 October 2008 and reported symptom onset of between 29 August and 19 October ( Figure 1 ). Of these 39 pneumonia case patients, 32 (82%) completed a survey and were enrolled ( Table 1 ). The 7 nonenrolled case patients were older and less likely to be AIAN than the 32 enrolled case patients and resided in remote communities that were difficult to access ( ) or could not be n p 5 located (
). The remainder of this report will focus on the n p 2 32 enrolled case patients.
Of the 32 enrolled case patients, 24 (75%) were male, 29 (91%) were 119 years old, 14 (44%) were у50 years old, and 23 (74%) were AIAN; all resided in 1 of 3 island communities (communities A, B, and C). These 3 communities accounted for 58% of the total island population. The distributions of age, sex, and race of the case patients differed from those of the residents of the 3 communities (Table 1 ). Ten case patients had severe disease (9 were admitted to a hospital and 1 died), and 3 of those patients who required hospital admission spent at least 24 h under intensive care ( (Figure 2) . Shortness of breath, wheezing, fever, and myalgia were very common, occurring in at least three-quarters of the case patients, whereas chest pain, chills, coryza, headache, sore throat, and nasal congestion occurred in more than one-half of the case patients. Diarrhea, vomiting, red eyes, and rash were less commonly reported. Chest radiographs were obtained for 30 case patients, and 26 (87%) had evidence of acute changes, including 12 (40%) with infiltrates in multiple lobes ( Table 2 ). All case patients received at least 1 course of antibiotic treatment, and none were given antiviral therapy. On presentation, 9 (28%) case patients were noted to have tachypnea and 14 (44%) had a room air oxygen saturation percentage of !95%.
HAdV-14 infection. Specimens from 31 of the 32 pneumonia case patients were tested for HAdV-14. Among these, 6 (19%) provided only a respiratory tract specimen, 6 (19%) provided only a serum sample, and 19 (61%) provided both. All of the 25 respiratory tract specimens were tested by PCR for HAdV-14, and 23 specimens (92%) were also tested by virus isolation. Eighteen case patients (56%) had confirmed HAdV-14 infection, with 1 or more positive laboratory test result. Three additional case patients, including the 1 case patient with no specimen available for testing, were known to have had close and sustained contact with a laboratory-confirmed HAdV-14-infected person and were designated as probable HAdV-14-infected case patients. The 18 laboratory-confirmed patients and 3 probable infected patients (66% of all case patients) were together considered to have HAdV-14 infection for the remaining analysis ( Figure 1 and Table 2 ). No virus other than HAdV-14 was isolated.
Among laboratory-confirmed case patients, HAdV-14 was detected in 11 (79%) of 14 respiratory tract swab specimens collected on days 0-13 after onset of illness and in 1 (13%) of 8 specimens collected on day 14 or later ( for the P p .005 difference). Antibodies to HAdV-14 were detected in 2 (33%) of 6 serum samples collected on days 0-13 and in 8 (73%) of 11 serum samples collected on day 14 or later ( for P p .2 difference).
The frequency of signs and symptoms among HAdV-14-infected case patients did not differ statistically significantly from that of the HAdV-14-uninfected case patients. The sequences of the E1A, hexon, and fiber genes of the HAdV-14 isolates obtained during this outbreak were all identical to those of the emergent HAdV-14 virus associated with outbreaks and cases detected in the United States since 2003 [15] .
Case-control investigation. Matched control participants were identified for each of the 32 pneumonia case patients (Tables 1 and 2 ). Case patient interviews were completed an average of 23 days (range, 1-48 days) after symptom onset. Control participants were interviewed between 18 and 26 October. Among the 32 control participants, 28 provided specimens for HAdV-14 testing, including 2 (7%) who provided only a respiratory tract specimen, 1 (4%) who provided only a serum sample, and 25 (89%) who provided both. All of the 27 respiratory tract specimens were tested by PCR for HAdV-14, and 24 (89%) were also tested by virus isolation.
Risk factors for pneumonia. Evidence of HAdV-14 infection was present in 21 (66%) of the 32 case patients and none of the 32 control participants ( ). In a matched-pair P ! .001 analysis (Table 3) , contact with a known HAdV-14-infected pneumonia case patient was strongly associated with pneumonia. Statistically significant associations with pneumonia were also found for current smoking, an underlying chronic medical condition, self-reported contact with another person with a cough, and having neither traveled off the island nor attended a large public social gathering in the 2 weeks prior to illness onset. COPD alone was the only individual underlying chronic medical condition that was statistically significantly associated with being a case patient. Other variables analyzed but not found to be statistically significantly different between case patients and control participants included race, hand-washing behavior, participation in the care of young children or elders, contact with a member of the military, number of household contacts, and home size. In a multivariable conditional logistic regression model, 3 risk factors were independently associated with pneumonia: contact with a known HAdV-14-infected case patient, current smoking, and lack of off-island travel or attendance at a large public social gathering (Table 3) .
When the analysis was restricted to the 20 pairs for which the case patient was HAdV-14-positive and the control participant had submitted specimens, 2 risk factors were statistically significantly associated with HAdV-14-associated pneumonia: current smoking (72% for case patients vs 17% for control participants;
) and known exposure to a case P p .002 patient who was later confirmed to be HAdV-14-positive by means of laboratory testing (70% for case patients vs 10% for control participants;
). Among the 32 pneumonia case P ! .001 patients, no risk factors were found to be statistically significantly associated with severe disease.
Comparison of HAdV-14-positive and HAdV-14-negative pneumonia case patients. Among the 32 pneumonia case patients, both current smoking and exposure to a confirmed HAdV-14-infected case patient were statistically significantly more common among those who were HAdV-14-positive (70% were smokers, and 64% had exposure to HAdV-14) than among those who were HAdV-14-negative (29% were smokers, and 10% had exposure to HAdV-14;
for both comparisons). P ! .05 Both risk factors remained statistically significantly associated with HAdV-14 disease when probable case patients and case patients with suboptimal specimens were excluded from the analysis.
Household transmission. The 32 pneumonia case patients resided in 28 households, including 4 households with 2 case patients each. Of these 28 households, 13 were either singlemember households or households in which only 1 member submitted a specimen, leaving 15 households in which to assess transmission. Of 55 members of these 15 case-patient households, 36 (65%) completed an interview (Table 4 ) and 30 (83%) of these provided specimens for HAdV-14 testing. The HAdV-14 secondary attack rate among these 30 individuals was 40% ( ) . n p 12
The 32 control participants resided in 32 households. Of the 70 contacts in these households, 39 (56%) completed an interview and 20 (51%) provided specimens for HAdV-14 testing. The HAdV-14 attack rate among these 20 individuals was 5% ( ; for comparison with case-patient household n p 1 P p .005 contacts).
Testing of respiratory tract specimens for other possible viral etiologies by means of viral culture was completed for 59% of case-patient household contacts and 44% of control-participant In addition, the sharing of smoking materials with one another was frequently reported, and most of these participants neither traveled off the island nor attended large social gatherings in the 2 weeks prior to symptom onset. Neg, negative; pos, positive.
household contacts. No pathogens other than HAdV-14 were recovered from the household contacts in either group. Several household characteristics, including household size, current smoking by at least 1 household member, severity of disease, and race, were examined for an association with transmission in households with an HAdV-14-infected case patient. Only current smoking was found to be statistically significantly associated with secondary cases of pneumonia in these households (100% vs 3%;
). P ! .007
Social interactions and HAdV-14-associated pneumonia. During the course of the interview, many pneumonia case patients named other case patients as recent ill contacts ( Figure  3 ). Furthermore, numerous case patients described close and sustained contact with these other case patients during the acute phase of their illness. Fourteen (67%) of the 21 HAdV-14-infected case patients were part of a single social network (Figure 3) , whose members often reported smoking and sharing smoking materials with other HAdV-14-infected case patients. Among the 14 case patients in this group, 13 (93%) had neither traveled off the island nor attended large social gatherings in the prior 2 weeks.
DISCUSSION
We describe an outbreak of community-acquired pneumonia on a rural, Southeast Alaska island in which two-thirds of case patients were found to be infected with HAdV-14, an emergent virus. In this outbreak, HAdV-14 produced a broad range of illness, from asymptomatic infection to severe pneumonia that required intensive care. One case patient died. Although there is no information to suggest how the virus was introduced on the island, data from the investigation suggest that after its introduction, the virus spread through close contact, as indicated by transmission within case-patient households and among members of a tight social network. Furthermore, evidence for wider transmission within the community was lacking, with no control participants and only 1 household contact of a control participant being infected.
We identified 3 independent risk factors for pneumonia: contact with a known HAdV-14-infected pneumonia case patient, current smoking, and having neither traveled off the island nor attended at a large public gathering in the recent past. The first of these would seem to be an obvious risk factor. The second, smoking, may have facilitated transmission, as suggested by the observation that two-thirds of HAdV-14-infected case patients reported smoking or sharing smoking materials with other HAdV-14-infected individuals. The significance of the third risk factor is less clear, but this factor may be a marker of being a part of a network of people who socialized frequently with one another but not with others.
The lack of evidence of HAdV-14 infection among control participants and the low rate (5%) observed among their household contacts suggest that widespread transmission on the island did not occur, either previously or during this pneumonia outbreak. This finding suggests that transmission of this HAdV-14 variant requires close person-to-person contact but that transmission is unlikely during most contact situations in the community. During a 2007 outbreak among healthy military recruits, 50% of previously HAdV-14-naive trainees (as demonstrated by preexposure antibody titers) were documented to have acquired infection within 6.5 weeks of arrival at the training facility [11] . This finding represents efficient transmission in a setting of close physical association and is consistent with the setting in which transmission appeared to occur in the investigation that we report here.
Compared with the residents of the communities where they resided, pneumonia case patients were older and more frequently male-a finding similar to reported HAdV-14 outbreaks in Oregon and Washington in 2007 [9, 10] . Other respiratory tract pathogens generally, and certain HAdV serotypes specifically, show similar age and sex predilections, but the mechanism responsible for this age predilection is not understood. Although previous reports suggested that underlying chronic illness may predispose an individual to severe HAdV-14 illness [9, 10] , the case-control investigation presented here was not large enough to thoroughly evaluate this issue. Nevertheless, our observation that some of the case patients in Alaska with severe disease were relatively young and previously healthy corresponds to findings of Tate et al [11] and raises the possibility that some persons are especially susceptible, possibly through a genetic host factor, to complications from HAdV-14 infection. The report by Tate et al [11] also noted that prior natural infection with HAdV-7, a species B1 HAdV, might confer protection from severe HAdV-14 disease in healthy military recruits, presumably due to heterotypic immunity. The possibility that HAdV-7 infection might protect an individual from serious HAdV-14 disease raises the possibility that the HAdV-7 vaccine in development by the military may also help decrease HAdV-14 disease or its severity [16, 17] .
These data have several limitations. There were differences in the nonenrolled case patients that may have caused an underrepresentation of the true extent of the outbreak on the island and led to an underestimate of the median age and percentage of non-AIAN race of the patients with pneumonia. However, the demographic and clinical characteristics identified among the case patients are consistent with those of other HAdV-14 outbreaks. Nevertheless, given the likely importance of close contact in sustaining transmission during this outbreak, an investigation of cases in the additional communities on the island, had they been accessible, would have been interesting. Another potential limitation was that the suboptimal timing of specimen collection could have resulted in misclassification bias. However, the observed differences between the HAdV-14-positive case patients and HAdV-14-negative case patients suggest at most a minor misclassification-that many or most of the noninfected persons had another etiology for their pneumonia. Finally, this island community is geographically unique, which limits the generalizability of our findings to other settings.
In conclusion, we found that the majority of HAdV-14 illness in this outbreak occurred among those who interacted closely and intensely with one another, shared smoking materials, had limited interaction with other groups on the island, and traveled infrequently off the island. Consistent with previous reports, this investigation found that HAdV-14 primarily circulated within groups of individuals who had close contact with one another, causing severe disease in a proportion of those infected, but did not transmit widely in the community.
